50 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
RecruitmentPrimary· through the recruitment process, up to 6 months from the start of the study
Number of participants that are randomized for the study
Group
Value
95% CI
Group TX (Telehealth Exercise)
19
Group TMX (Telehealth Exercise and Mindfulness)
21
AttendancePrimary· post-intervention (at 8-weeks)
Proportion of sessions attended
Group
Value
95% CI
Group TX (Telehealth Exercise)
68
± 34
Group TMX (Telehealth Exercise and Mindfulness)
54
± 39
Retention RatePrimary· post-intervention visit (at the end of 8-weeks)
Proportion of participants who complete patient-reported outcome surveys
Group
Value
95% CI
Group TX (Telehealth Exercise)
19
Group TMX (Telehealth Exercise and Mindfulness)
18
Participant Feedback SurveyPrimary· 8-week
Custom scale measuring feedback on interventionists and interventions. Scores range from 0-4 (0 - Strongly Disagree, 1 - Disagree, 2 - Neither Agree no Disagree, 3 - Agree, and 4 - Strongly Agree)
The exercise instructor demonstrated good knowledge
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.56
2 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.29
2 – 4
The exercise instructor was a good role model
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.44
2 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.35
2 – 4
The exercise instructor explained lessons clearly
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.33
1 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.38
2 – 4
The exercise instructor was engaging
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.39
2 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.44
2 – 4
The exercise instructor was helpful/answered all questions
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.33
1 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.44
2 – 4
I enjoyed the exercise lessons
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.11
1 – 4
Group TMX (Telehealth Exercise and Mindfulness)
2.88
1 – 4
I was engaged in the exercise lessons
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.39
1 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.12
2 – 4
I was able to understand the exercise lessons
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.56
2 – 4
Group TMX (Telehealth Exercise and Mindfulness)
3.24
2 – 4
Satisfaction ScalePrimary· 8-week
Custom 4-item (0-10 scale) to determine satisfaction with individual components of the intervention (i.e.,, exercise, mindfulness, telehealth, and overall satisfaction). There are 4 items and each item is scored separately. Higher scores for each item mean greater satisfaction for that dimension.
Exercise component
Group
Value
95% CI
Group TX (Telehealth Exercise)
8.1
2.0 – 10.0
Group TMX (Telehealth Exercise and Mindfulness)
8.2
5.0 – 10.0
Mindfulness Component
Group
Value
95% CI
Group TMX (Telehealth Exercise and Mindfulness)
7.3
2.0 – 10.0
Telehealth component
Group
Value
95% CI
Group TX (Telehealth Exercise)
8.1
1.0 – 10.0
Group TMX (Telehealth Exercise and Mindfulness)
7.9
5.0 – 10.0
General participation
Group
Value
95% CI
Group TX (Telehealth Exercise)
7.9
1.0 – 10.0
Group TMX (Telehealth Exercise and Mindfulness)
8.1
5.0 – 10.0
Knee Injury and Osteoarthritis Outcome ScoreSecondary· baseline, 8-week, 14-week
Patient-reported outcome for knee pain and disability; a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.
Pain Baseline
Group
Value
95% CI
Group TX (Telehealth Exercise)
61.3
57.6 – 64.9
Group TMX (Telehealth Exercise and Mindfulness)
57.7
52.6 – 62.7
Pain Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
63.7
57.9 – 69.5
Group TMX (Telehealth Exercise and Mindfulness)
61.8
54.4 – 69.1
Pain Week-14
Group
Value
95% CI
Group TX (Telehealth Exercise)
63.8
57.3 – 70.3
Group TMX (Telehealth Exercise and Mindfulness)
64.2
57 – 71.4
Symptoms Baseline
Group
Value
95% CI
Group TX (Telehealth Exercise)
59.7
54.3 – 65
Group TMX (Telehealth Exercise and Mindfulness)
59.4
53.9 – 65
Symptoms Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
63.1
58.5 – 67.8
Group TMX (Telehealth Exercise and Mindfulness)
59.9
53.7 – 66.1
Symptoms Week-14
Group
Value
95% CI
Group TX (Telehealth Exercise)
68.8
63 – 74.5
Group TMX (Telehealth Exercise and Mindfulness)
62.1
54 – 70.3
Activity of Daily Living Baseline
Group
Value
95% CI
Group TX (Telehealth Exercise)
72.1
66.7 – 77.6
Group TMX (Telehealth Exercise and Mindfulness)
63
57.8 – 68.1
Activity of Daily Living Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
72.6
66.4 – 78.8
Group TMX (Telehealth Exercise and Mindfulness)
68.2
60.3 – 76.1
Pain, Enjoyment, General Activity ScaleSecondary· baseline, 8-week, 14-week
Assesses Pain Intensity and Interference. the response range is 0-10; the PEG scale score is the mean of the three individual item scores. Higher scores represent worse pain.
average rating of knee pain from 0-10, where 0 represents no pain and 10 represents worst pain imaginable, in the past week in a nominated activity selected at baseline
Baseline
Group
Value
95% CI
Group TX (Telehealth Exercise)
6.1
5.3 – 6.9
Group TMX (Telehealth Exercise and Mindfulness)
6.5
6.1 – 6.9
Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
5.1
4 – 6.2
Group TMX (Telehealth Exercise and Mindfulness)
5.2
4.4 – 5.9
Week-14
Group
Value
95% CI
Group TX (Telehealth Exercise)
4.8
3.8 – 5.9
Group TMX (Telehealth Exercise and Mindfulness)
4.8
3.8 – 5.7
Participant Global Impression of ChangeSecondary· 8-week, 14-week
participant's rating of change in condition on a 14-point scale ranging from "a very great deal worse" to "a very great deal better". Values range from -7 to +7 (excluding 0). Score \>=1 represent improvement and scores \<= -1 represent worsening.
Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
2.2
1 – 3.4
Group TMX (Telehealth Exercise and Mindfulness)
2.4
1.2 – 3.7
Week-14
Group
Value
95% CI
Group TX (Telehealth Exercise)
1.4
0.1 – 2.7
Group TMX (Telehealth Exercise and Mindfulness)
2.2
1.1 – 3.3
Patient Global Assessment of OsteoarthritisSecondary· baseline, 8-week, 14-week
participant's assessment of impact of osteoarthritis on their general health on a 0-100 mm scale. higher scores represent higher impact of disease or worse global health
3-item scale which measures of catastrophizing related to pain. Each item is rated on a 5-point scale: 0 (Not at all) to 4 (all the time).
Baseline
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.5
2.7 – 4.4
Group TMX (Telehealth Exercise and Mindfulness)
3.9
2.9 – 4.9
Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.4
2.3 – 4.6
Group TMX (Telehealth Exercise and Mindfulness)
3.1
2 – 4.1
Widespread Pain Index Symptom Severity ScaleSecondary· baseline, 8-week
self-report on severity of cognitive symptoms such as fatigue, trouble thinking or remembering, waking up tired, and other physical symptoms such as headache, dizziness, etc. Each symptom is scored on a 4-point scale where 0 indicates no problem and 3 indicates severe problem. Scores are calculated by summing items, with higher scores (out of a maximum score of 12) indicating greater symptom severity.
Baseline
Group
Value
95% CI
Group TX (Telehealth Exercise)
3.9
3 – 4.8
Group TMX (Telehealth Exercise and Mindfulness)
3.1
2.2 – 4.1
Week-8
Group
Value
95% CI
Group TX (Telehealth Exercise)
4.1
2.9 – 5.3
Group TMX (Telehealth Exercise and Mindfulness)
3.7
2.6 – 4.9
Adverse events — posted to ClinicalTrials.gov
Time frame: 14-weeks.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
This is a parallel-arm mixed-methods randomized controlled trial to investigate the feasibility of telehealth delivered mindful exercise vs. usual exercise interventions for people with knee osteoarthritis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
· EARLY_PHASE1
· recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte
· NA
· recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment
· NA
· recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis
· NA
· recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA
· NA
· recruiting
Other Boston University Charles River Campus trials
Trials by the same sponsor.
NCT07461584 — Memory Enhancement in Aging With Optimal Dosing
· EARLY_PHASE1
· not yet recruiting
NCT07208318 — Restructuring the Alpha-Gamma Code in Aging Vision
· EARLY_PHASE1
· not yet recruiting
NCT06182241 — Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston University Charles River Campus
Last refreshed: 16 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05524116.